175 filings
10-Q
2024 Q1
VRNA
Verona Pharma Plc
Quarterly report
10 May 24
9:09am
S-8
VRNA
Verona Pharma Plc
10 May 24
Registration of securities for employees
8:53am
8-K
VRNA
Verona Pharma Plc
9 May 24
Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
7:22am
8-K
VRNA
Verona Pharma Plc
9 May 24
Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS
7:18am
8-K
VRNA
Verona Pharma Plc
30 Apr 24
Submission of Matters to a Vote of Security Holders
4:11pm
ARS
hmn77krrrkhcabyr9
20 Mar 24
Annual report to shareholders
8:47am
PRE 14A
fuo7hs
8 Mar 24
Preliminary proxy
4:18pm
8-K
mj0woh0 604j
29 Feb 24
Verona Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
6:08am
8-K
gn553wn8ok226mzs
2 Feb 24
Departure of Directors or Certain Officers
6:02am
8-K
lznlepg t2
2 Jan 24
Strengthens financial flexibility to support the Company’s continued growth
6:02am
8-K
6tcquux95cwnhg r7ytj
18 Dec 23
Changes in Registrant's Certifying Accountant
4:15pm
8-K
kfovrtpx s4n
2 Nov 23
Verona Pharma Reports Third Quarter 2023 Financial Results and Provides Corporate Update
6:24am
8-K
861s ls79p26p0yj50dh
11 Sep 23
Other Events
6:02am
8-K
coi8692g
1 Sep 23
Entry into a Material Definitive Agreement
4:05pm
8-K
7t1gm7o9u pchee5
3 Aug 23
Verona Pharma Reports Second Quarter 2023 Financial Results and Provides Corporate Update
6:11am
S-8
ql5pq698x7 8eursq6ct
9 May 23
Registration of securities for employees
4:08pm